Concepedia

Krishna Mohan Vadrevu

KM

Statistics

Publications

20

Citations

2K

H-Index

18

Active since

2018

Affiliations

Bharat Biotech (India)(Current)

ICMR-National Institute of Virology

Indian Council of Medical Research

All India Institute of Medical Sciences

Nizam's Institute of Medical Sciences

Krishna Mohan Vadrevu is an author at Bharat Biotech (India) specializing in vaccination, vaccinology, and veterinary medicine.

Publications per year

2018–2023

20

Publications

20

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 438 citations · Full text

, , +12

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 365 citations · Full text

, , +17

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

Raches Ella, Siddarth Reddy, William C. Blackwelder et al. · The Lancet · 2021 · 362 citations · Full text

, , +12

Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2

Gajanan Sapkal, Pragya D. Yadav, Raches Ella et al. · Journal of Travel Medicine · 2021 · 129 citations · Full text

, , +14

Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation

Brunda Ganneru, Harsh Jogdand, Vijaya Kumar Daram et al. · iScience · 2021 · 94 citations · Full text

, , +17

1–5 of 20